Current News Releases
Current News Releases
Researchers caution that larger studies are needed to assess the potential for clinical use
In a report of a proof-of-principle study of patients with colon and other cancers for whom standard therapies failed, researchers at the Johns Hopkins Kimmel Cancer Center say that mistakes in so-called mismatch repair genes, first identified by Johns Hopkins and other scientists two decades ago, may accurately predict who will respond to certain immunotherapy drugs known as PD-1 inhibitors. Such drugs aim to disarm systems developed by cancer cells to evade detection and destruction by immune system cells.
Lightly stimulating the brain with electricity may improve short-term memory in people with schizophrenia, according to a new study by researchers at the Johns Hopkins University School of Medicine.
On Wednesday, May 27, Johns Hopkins Medicine announced that the United Way Charity Event, “Dancing with the Hopkins Stars,” held the previous night, raised more than $50,000 to support Maryland Unites, a United Way program that provides humanitarian relief and emergency support to nonprofits in Baltimore neighborhoods.
Johns Hopkins faculty and staff members show off their dance moves by competing in "Dancing with the Hopkins Stars" in support of United Way.
Reporting on their study with lab-grown human cells, researchers at The Johns Hopkins University and the University of Maryland say that blocking a second blood vessel growth protein, along with one that is already well-known, could offer a new way to treat and prevent a blinding eye disease caused by diabetes.
Julie Lange, M.D., an associate professor of surgery, oncology and dermatology at the Johns Hopkins University School of Medicine, and John Fetting, M.D., an associate professor of oncology and medicine, have been inducted into the Miller-Coulson Academy of Clinical Excellence.
A novel two-drug combination has the potential to target and restore a defective protein underlying cystic fibrosis (CF), according to two phase III clinical trials conducted at 187 medical centers around the world, including Johns Hopkins.
A distinguished group of 268 graduates will embark on their future careers as physicians and scientists at the convocation ceremony of the Johns Hopkins University School of Medicine. A total of 113 M.D. degrees, 138 Ph.D. degrees, 15 master’s degrees and two postbaccalaureate certificates will be conferred.
A multidisciplinary team led by Johns Hopkins researcher Venu Raman, Ph.D., with notable contributions from Guus Bol, Farhad Vesuna and Phuoc Tran of Johns Hopkins, has identified a new therapy for lung cancer, the most common cancer worldwide.
Sending teen girls periodic text messages reminding them to follow through on their clinic appointments for periodic birth control injections can go a long way toward improving timing and adherence to contraception in an age group that is notoriously noncompliant, according to a small study from the Johns Hopkins Children’s Center.
Study of thousands of human bones reveals gradual decline as species grew more “domestic”
Modern lifestyles have famously made humans heavier, but, in one particular way, noticeably lighter weight than our hunter-gatherer ancestors: in the bones. Now a new study of the bones of hundreds of humans who lived during the past 33,000 years in Europe finds the rise of agriculture and a corresponding fall in mobility drove the change, rather than urbanization, nutrition or other factors.
Site aims to help consumers decipher the institution’s performance scores and make better-informed health care decisions
New building will accommodate more local startups
A groundbreaking ceremony will be held for 1812 Ashland on Friday, May 15. The building will house Johns Hopkins offices, including FastForward East, a program designed to move academic findings and translational research into the commercial marketplace.
Sahar Soleimanifard, a first-year medical student at The Johns Hopkins University, is among 30 graduate students receiving 2015 Paul and Daisy Soros Fellowships for New Americans.
Johns Hopkins Medicine announced today the appointment of Robert A. Kasdin to the newly created role of senior vice president and chief operating officer. Kasdin comes to Johns Hopkins Medicine from Columbia University, where he has been senior executive vice president since 2002. He starts on July 1.
Increasingly common illness has high toll: 300,000 stricken, $1.3 billion in treatment costs per year
Fundamental research into the causes and cures of post-treatment Lyme disease syndrome now has its first home base at a major U.S. medical research center with the launch of the Johns Hopkins Lyme Disease Clinical Research Center.
The culmination of the DreamIt Health Baltimore accelerator program, a four-month intensive boot camp for health information technology entrepreneurs co-sponsored by Johns Hopkins, concludes on Wednesday, May 13, at DreamIt Health Demo Day. This one-day capstone event affords startup companies the opportunity to share their progress and plans for the future with an audience of industry leaders, possible investors and potential customers.